Clinical Trials Directory

Trials / Conditions / Ovarian Carcinosarcoma

Ovarian Carcinosarcoma

18 registered clinical trials studyying Ovarian Carcinosarcoma — 4 currently recruiting.

StatusTrialSponsorPhase
RecruitingA Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer
NCT05902988
Volastra Therapeutics, Inc.Phase 1 / Phase 2
RecruitingEPOCH: Eribulin and Pembrolizumab in Ovarian/Uterine Carcinosarcoma
NCT05619913
Australia New Zealand Gynaecological Oncology GroupPhase 2
RecruitingAPL-2 and Pembrolizumab Versus APL-2, Pembrolizumab and Bevacizumab Versus Bevacizumab Alone for the Treatment
NCT04919629
Roswell Park Cancer InstitutePhase 2
TerminatedOlaparib and Entinostat in Patients With Recurrent, Platinum-Refractory, Resistant Ovarian, Primary Peritoneal
NCT03924245
Vanderbilt-Ingram Cancer CenterPhase 1
RecruitingRecurrent Ovarian CarcinoSarcoma Anti-pd-1 Niraparib
NCT03651206
ARCAGY/ GINECO GROUPPhase 2 / Phase 3
TerminatedThe Effects of Exercise on Distress, Quality of Life, and Biomarkers in Ovarian Cancer Survivors
NCT03641287
University of WashingtonN/A
CompletedDual mTorc Inhibition in advanCed/Recurrent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer (o
NCT03648489
Imperial College LondonPhase 2
Active Not RecruitingLN-145 or LN-145-S1 in Treating Patients With Relapsed or Refractory Ovarian Cancer, Triple Negative Breast Ca
NCT03449108
M.D. Anderson Cancer CenterPhase 2
TerminatedMV-NIS or Investigator's Choice Chemotherapy in Treating Patients With Ovarian, Fallopian, or Peritoneal Cance
NCT02364713
Mayo ClinicPhase 2
CompletedNab-Paclitaxel and Bevacizumab in Treating Patients With Unresectable Stage IV Melanoma or Gynecological Cance
NCT02020707
Mayo ClinicPhase 1
CompletedChanges in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritone
NCT01080521
Gynecologic Oncology Group—
CompletedCarboplatin, Paclitaxel, Bevacizumab, and Veliparib in Treating Patients With Newly Diagnosed Stage II-IV Ovar
NCT00989651
National Cancer Institute (NCI)Phase 1
CompletedTemsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Isl
NCT01010126
National Cancer Institute (NCI)Phase 2
UnknownPaclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed, Persistent or Recurrent Ut
NCT00954174
GOG FoundationPhase 3
CompletedStudy of Bevacizumab Followed by Bevacizumab Consolidation for Ovarian Cancer
NCT00511992
University of OklahomaPhase 2
CompletedZiv-aflibercept in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gynecologic Soft Tissu
NCT00390234
National Cancer Institute (NCI)Phase 2
CompletedCarboplatin, Paclitaxel, and Pegfilgrastim in Treating Patients With Stage III or Stage IV Ovarian Epithelial,
NCT00352300
Gynecologic Oncology GroupPhase 1
CompletedCarboplatin and Paclitaxel With or Without Bevacizumab Compared to Docetaxel, Carboplatin, and Paclitaxel in T
NCT00085358
National Cancer Institute (NCI)Phase 1